Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9348 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8958 |
High Similarity |
NPD2534 |
Approved |
0.8958 |
High Similarity |
NPD2533 |
Approved |
0.8958 |
High Similarity |
NPD2532 |
Approved |
0.8733 |
High Similarity |
NPD7819 |
Suspended |
0.8472 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8472 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.844 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8378 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8366 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8301 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8299 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8298 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8247 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8194 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8165 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8141 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8133 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8129 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8125 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8113 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8113 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8089 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8089 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8054 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8026 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8015 |
Intermediate Similarity |
NPD9545 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7974 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7962 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7961 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7927 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7927 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7914 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7867 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7843 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7817 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD411 |
Approved |
0.7786 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7755 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7748 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7742 |
Intermediate Similarity |
NPD920 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD2654 |
Approved |
0.763 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD37 |
Approved |
0.7607 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7593 |
Intermediate Similarity |
NPD919 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7571 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7568 |
Intermediate Similarity |
NPD943 |
Approved |
0.756 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD3764 |
Approved |
0.755 |
Intermediate Similarity |
NPD5406 |
Approved |
0.755 |
Intermediate Similarity |
NPD5408 |
Approved |
0.755 |
Intermediate Similarity |
NPD5404 |
Approved |
0.755 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7452 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7415 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7397 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7394 |
Intermediate Similarity |
NPD17 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7349 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7326 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7324 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD74 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7228 |
Approved |
0.726 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7255 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7234 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7206 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7206 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7206 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD5242 |
Approved |
0.72 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7162
|
Intermediate Similarity |
NPD5647 |
Approved |